neostigmine has been researched along with Exophthalmos in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Exophthalmos: Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HATCH, HA | 1 |
| Agarwal, M | 1 |
| Jain, AC | 1 |
2 other studies available for neostigmine and Exophthalmos
| Article | Year |
|---|---|
Myasthenia gravis: report of a case with exophthalmos, without hyperthyroidism, relieved by neostigmine.
Topics: Exophthalmos; Humans; Hyperthyroidism; Myasthenia Gravis; Neostigmine | 1952 |
Thyrotoxic exophthalmos with ophthalmoplegia and ocular myasthenia gravis.
Topics: Adult; Exophthalmos; Eye Diseases; Eyelids; Humans; Male; Myasthenia Gravis; Neostigmine; Thyrotropi | 1965 |